Risk factors associated with safety of preschool peanut oral immunotherapy

Risk factors associated with safety of preschool peanut oral immunotherapy

Background: An understanding of how patient characteristics such as age, baseline peanut-specific IgE, and atopic comorbidities may influence potential safety outcomes during peanut oral immunotherapy (P-OIT) could aid in shared decision making between clinicians and patient families. Objective: Thi...

Full description

Bibliographic Details
Main Authors: Duva Karunakaran, BSc, Edmond S. Chan, MD, Qian Zhang, Jeffrey N. Bone, Stuart Carr, MD, Sandeep Kapur, MD, Gregory A. Rex, MD, Mary McHenry, MD, Scott B. Cameron, MD, PhD, Victoria E. Cook, MD, Sara Leo, MD, Tiffany Wong, MD, Thomas V. Gerstner, MD, Joanne Yeung, MD, Elissa M. Abrams, MD, Raymond Mak, MD, Stephanie C. Erdle, MD, Lianne Soller, PhD
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Oral immunotherapy
personalized medicine
shared decision making
peanut allergy
Online Access:http://www.sciencedirect.com/science/article/pii/S277282932300019X

Internet

http://www.sciencedirect.com/science/article/pii/S277282932300019X

Similar Items